Skip to main content
NIH funding notice PAR-18-196

Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional)

Closed on May 7, 2020.

Posted
November 1, 2017
Close date
May 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $713,762 in first-year total cost, median $713,762.

Most frequent study sections

  1. Clinical, Treatment and Health Services Research Study Section[AA-3]1

Most frequent institutions

  1. KAISER FOUNDATION RESEARCH INSTITUTE1
Competing awards under PAR-18-196 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems1R01AA028211-01STERLING, STACY ANNKAISER FOUNDATION RESEARCH INSTITUTE, CA$713,762AA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-196: Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional) | ScienceDex | ConductScience